Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2039 (LINC02039) is a human long intergenic non-coding RNA (lincRNA) gene located on chromosome 5q23.2 (genomic coordinates: chr5:126179576–126193849)[3][5]. As a lincRNA, LINC02039 does not encode a protein but instead functions at the RNA level, potentially regulating gene expression, interacting with chromatin modification complexes or RNA-binding proteins, and contributing to diverse cellular processes[7]. Although lincRNAs as a class have established importance in gene regulation and disease, there is currently no direct evidence linking LINC02039 specifically to well-characterized biological functions or roles in human disease, nor is it recognized as a direct therapeutic target[1][5][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2039 (LINC02039).